Omega Ophthalmics
Omega Ophthalmics enhances cataract surgery with intraocular lenses for in-eye AR/VR tech.
Founded
2013Omega Ophthalmics enhances cataract surgery with intraocular lenses for in-eye AR/VR tech.
Founded with a vision to revolutionize cataract surgery, Omega Ophthalmics focuses on enhancing visual outcomes through innovative intraocular lens technology. Their flagship product, the Gemini Refractive Capsule™, aims to significantly increase the number of patients who achieve "glasses-free" vision post-surgery. Omega Ophthalmics integrates advanced AR/VR capabilities within their lenses, positioning themselves at the forefront of ophthalmic technology. Their market focus is on improving the efficacy of cataract surgeries, which are among the most common procedures in the United States.
Omega Ophthalmics has garnered attention from notable figures in the medical and tech industries, although specific names and investors are not disclosed. Their key achievement lies in the development of the Gemini Refractive Capsule™, which represents a significant advancement in intraocular lens design. The overall impact of Omega Ophthalmics is profound, as they strive to enhance the quality of life for millions of cataract patients by reducing dependency on glasses and introducing cutting-edge in-eye technology.
Companies similar to Omega Ophthalmics include Clearsight, ReaLens, STAAR Surgical and OculoMotor Technologies.
Omega Ophthalmics was founded in 2013.
Omega Ophthalmics' headquarters is located in Lexington, KY, US.
Omega Ophthalmics' most recent funding round was for $450k (USD) in July 2022.
As of Jul 19, 2022, Omega Ophthalmics has disclosed funding of $450k (USD). Undisclosed round amounts are excluded.
Omega Ophthalmics has 75 employees as of Feb 5, 2024.
